indazoles has been researched along with Pleural Effusion, Malignant in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asai, K; Eguchi, Y; Hirata, K; Kawaguchi, T; Kojima, K; Ohsawa, M; Sugitani, A | 1 |
Hatano, K; Ishizuya, Y; Kakimoto, KI; Nakai, Y; Nakayama, M; Nishimura, K; Okusa, T | 1 |
2 other study(ies) available for indazoles and Pleural Effusion, Malignant
Article | Year |
---|---|
Primary Pleural Synovial Sarcoma Treated with Pazopanib.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Doxorubicin; Dyspnea; Fatal Outcome; Female; Humans; Ifosfamide; Indazoles; Neoplasm Recurrence, Local; Pleural Effusion, Malignant; Pleural Neoplasms; Pyrimidines; Sarcoma, Synovial; Sulfonamides | 2015 |
[A Case of Renal Cell Carcinoma with Malignant Pleural Effusion Showing Marked Response to Axitinib].
Topics: Adult; Axitinib; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Nephrectomy; Pleural Effusion, Malignant; Protein Kinase Inhibitors; Tomography, X-Ray Computed | 2016 |